EP0641785A4 - Triazolylated tertiary amine compound or salt thereof. - Google Patents

Triazolylated tertiary amine compound or salt thereof.

Info

Publication number
EP0641785A4
EP0641785A4 EP19920918529 EP92918529A EP0641785A4 EP 0641785 A4 EP0641785 A4 EP 0641785A4 EP 19920918529 EP19920918529 EP 19920918529 EP 92918529 A EP92918529 A EP 92918529A EP 0641785 A4 EP0641785 A4 EP 0641785A4
Authority
EP
European Patent Office
Prior art keywords
heterocyclic group
triazolylated
salt
tertiary amine
amine compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19920918529
Other languages
German (de)
French (fr)
Other versions
EP0641785A1 (en
EP0641785B1 (en
Inventor
Minoru Okada
Eiji Kawaminami
Toru Yoden
Masafumi Kudou
Yasuo Isomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of EP0641785A4 publication Critical patent/EP0641785A4/en
Publication of EP0641785A1 publication Critical patent/EP0641785A1/en
Application granted granted Critical
Publication of EP0641785B1 publication Critical patent/EP0641785B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

A triazolylated tertiary amine compound represented by general formula (I) or a salt thereof, having an aromatase inhibitory activity and being useful for preventing and treating breast cancer, mastopathy, endometriosis, prostatomegaly, etc., wherein A represents a single bond, lower alkylene or carbonyl; B represents lower alkyl, aryl, a 5- or 6- membered heterocyclic group, or a bicyclic fused heterocyclic group; D represents aryl, a 5- or 6-membered heterocyclic group, or a bicyclic fused heterocyclic group; and E represents 4H-1,2,4-triazolyl, 1H-1,2,4-triazolyl or 1H-1,2,3-triazolyl. <CHEM>
EP92918529A 1991-09-02 1992-08-27 Triazolylated tertiary amine compound or salt thereof Expired - Lifetime EP0641785B1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP248268/91 1991-09-02
JP24826891 1991-09-02
JP24826891 1991-09-02
JP344011/91 1991-12-02
JP34401191 1991-12-02
JP34401191 1991-12-02
PCT/JP1992/001089 WO1993005027A1 (en) 1991-09-02 1992-08-27 Triazolylated tertiary amine compound or salt thereof

Publications (3)

Publication Number Publication Date
EP0641785A4 true EP0641785A4 (en) 1994-06-16
EP0641785A1 EP0641785A1 (en) 1995-03-08
EP0641785B1 EP0641785B1 (en) 1999-10-27

Family

ID=26538684

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92918529A Expired - Lifetime EP0641785B1 (en) 1991-09-02 1992-08-27 Triazolylated tertiary amine compound or salt thereof

Country Status (20)

Country Link
US (1) US5674886A (en)
EP (1) EP0641785B1 (en)
KR (1) KR100204697B1 (en)
CN (1) CN1035817C (en)
AT (1) ATE186052T1 (en)
AU (1) AU665569B2 (en)
BG (1) BG61688B1 (en)
CA (1) CA2116773C (en)
DE (1) DE69230225T2 (en)
ES (1) ES2139605T3 (en)
FI (1) FI940988A (en)
HU (1) HU220863B1 (en)
MX (1) MX9204996A (en)
NO (1) NO305284B1 (en)
PT (1) PT100821B (en)
RO (1) RO114129B1 (en)
RU (1) RU2124010C1 (en)
TW (1) TW225526B (en)
UA (1) UA41295C2 (en)
WO (1) WO1993005027A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6420400B1 (en) 2000-04-07 2002-07-16 Kinetek Pharmaceuticals, Inc. Antiproliferative 1,2,3-thiadiazole compounds
US7022702B2 (en) 2000-04-07 2006-04-04 Qlt Inc. Antiproliferative 1,2,3-thiadiazole compounds
PL363316A1 (en) * 2000-12-22 2004-11-15 Ortho Mc Neil Pharmaceutical, Inc. Substituted triazole diamine derivatives as kinase inhibitors
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
WO2003045925A1 (en) * 2001-11-21 2003-06-05 Sterix Limited 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
GB0127923D0 (en) * 2001-11-21 2002-01-16 Sterix Ltd Compound
JP2004196795A (en) * 2002-12-16 2004-07-15 Wyeth N-phenyl-3-cyclopropylpyrazole-4-carbonitrile as external parasiticide
US6737433B1 (en) 2002-12-16 2004-05-18 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors and pharmaceutical compositions containing them
AU2011226950B9 (en) * 2003-12-15 2013-04-11 Laboratoire Theramex 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them
TW200533668A (en) * 2003-12-15 2005-10-16 Theramex 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
EP1544195A1 (en) * 2003-12-15 2005-06-22 Laboratoire Theramex 1-N-phenyl-amino- 1H-imidazole derivatives and pharmaceutical compositions containing them
GB0411562D0 (en) 2004-05-24 2004-06-23 Sterix Ltd Compound
US20120230914A1 (en) * 2009-07-03 2012-09-13 Riken Labeling compound for pet
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN113387894B (en) * 2021-06-22 2023-02-24 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) 1-N-benzene acetonitrile amido-triazole and pyrimidine derivative, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283245A1 (en) * 1987-03-20 1988-09-21 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0324359A1 (en) * 1988-01-11 1989-07-19 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazol- and indazolpyridin amines, a process for their preparation and their use as medicaments
WO1990014338A1 (en) * 1989-05-20 1990-11-29 Fisons Plc Anti-inflammatory 4-aminophenol derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4749713A (en) 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
CH677925A5 (en) * 1986-12-03 1991-07-15 Sandoz Ag
US5041458A (en) 1987-03-20 1991-08-20 E. I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
NZ224714A (en) 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283245A1 (en) * 1987-03-20 1988-09-21 E.I. Du Pont De Nemours And Company Fungicidal aminotriazoles and aminoimidazoles
EP0324359A1 (en) * 1988-01-11 1989-07-19 Hoechst-Roussel Pharmaceuticals Incorporated Pyrazol- and indazolpyridin amines, a process for their preparation and their use as medicaments
WO1990014338A1 (en) * 1989-05-20 1990-11-29 Fisons Plc Anti-inflammatory 4-aminophenol derivatives

Also Published As

Publication number Publication date
UA41295C2 (en) 2001-09-17
AU665569B2 (en) 1996-01-11
EP0641785A1 (en) 1995-03-08
TW225526B (en) 1994-06-21
ATE186052T1 (en) 1999-11-15
RU2124010C1 (en) 1998-12-27
US5674886A (en) 1997-10-07
NO305284B1 (en) 1999-05-03
NO940686D0 (en) 1994-02-28
CA2116773A1 (en) 1993-03-18
PT100821A (en) 1993-11-30
FI940988A0 (en) 1994-03-02
WO1993005027A1 (en) 1993-03-18
DE69230225D1 (en) 1999-12-02
HU220863B1 (en) 2002-06-29
DE69230225T2 (en) 2000-05-31
BG61688B1 (en) 1998-03-31
NO940686L (en) 1994-04-29
HU9400611D0 (en) 1994-09-28
HUT67249A (en) 1995-03-28
RO114129B1 (en) 1999-01-29
BG98618A (en) 1995-03-31
CN1035817C (en) 1997-09-10
EP0641785B1 (en) 1999-10-27
ES2139605T3 (en) 2000-02-16
AU2487492A (en) 1993-04-05
CN1069974A (en) 1993-03-17
FI940988A (en) 1994-04-05
PT100821B (en) 1999-07-30
MX9204996A (en) 1993-08-01
CA2116773C (en) 2002-12-10
KR100204697B1 (en) 1999-06-15

Similar Documents

Publication Publication Date Title
TW225526B (en)
GR3026471T3 (en) Novel benzothiophene derivative.
FI913640A0 (en) FOER FARING FRAMSTAELLNING AV NITRILER.
ATE214055T1 (en) RETINOID POTENTIFIING COMPOUNDS
HU9700069D0 (en) Heterocyclic tachykinine-receptor antagonists
RU94016190A (en) TRIAZOLYL SUBSTITUTED TERTIARY AMINE COMPOUNDS AND THEIR SALTS, METHOD OF THEIR RECEIVING AND CONTAINING THEIR AROMATASE INHIBITOR AND PHARMACEUTICAL COMPOSITION
ES2130258T3 (en) SUBSTITUTED TERTIARY AMINO COMPOUND OR SALT FROM THIS COMPOUND.
MY103241A (en) Imidazole and 1,2,4 triazole derivatives
EP0247760A3 (en) Benzoheterocyclic fungicides
GR81836B (en)
TW222268B (en)
ES2003100A6 (en) Imidazoles, their preparation and their use as fungicides.
NO179755C (en) Process for the preparation of deoxymulundocandin
ES2021476B3 (en) AZOLYL METHYL CYCLOPROPAN AND ITS APPLICATION AS A PLANT PROTECTIVE MEDIA
JPS57106666A (en) N-substituted imidazoles
GR3019145T3 (en) Fungicidal furanone derivatives
ES2055262T3 (en) DERIVATIVES OF 1-HYDROXY-1,2,4-TRIAZOLE AND THE CONTAINING FUNGICIDES AND GROWTH REGULATING AGENTS.
FR2248274A1 (en) Herbicidal triazinyl amino triazoles - prepd. from a chloro-triazine and an amino-triazole
TH9116A (en) Helopropgil Compounds, Mixtures, Uses and Processing Methods of this compound.
AU3673089A (en) (1,3-imidazole, triazole pyrimidine or pyridine) amide N-substituted compounds with antifungal action
BA97145B1 (en) Process for the preparation of 2- (2,4 difluorophenyl) -1,3-bis- (1H-1,2,4-thiazol-1-yl) -propan-2-ol

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL SE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940303

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL SE

17Q First examination report despatched

Effective date: 19970807

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19991027

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19991027

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19991027

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19991027

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19991027

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19991027

REF Corresponds to:

Ref document number: 186052

Country of ref document: AT

Date of ref document: 19991115

Kind code of ref document: T

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ISOMURA, YASUO

Inventor name: KUDOU, MASAFUMI

Inventor name: YODEN, TORU

Inventor name: KAWAMINAMI, EIJI

Inventor name: OKADA, MINORU

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69230225

Country of ref document: DE

Date of ref document: 19991202

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: JACOBACCI & PERANI S.P.A.

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000127

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2139605

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000827

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000827

26N No opposition filed
REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

NLT1 Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1

Owner name: ASTELLAS PHARMA INC.

REG Reference to a national code

Ref country code: FR

Ref legal event code: CD

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20080815

Year of fee payment: 17

Ref country code: ES

Payment date: 20080826

Year of fee payment: 17

Ref country code: DE

Payment date: 20080912

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20080827

Year of fee payment: 17

Ref country code: FR

Payment date: 20080818

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20080903

Year of fee payment: 17

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20100301

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20090827

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20100430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100301

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090831

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100302

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20090828

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090827

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090828